Metraipolis › archive › dc_11237fc5a49b
Beyond the hype: re-evaluating efficacy metrics and modeling rigor for MSC-EVs-based therapy in acute brain injury — Europe PMC PMID:41426594
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41426594
- DOI
- 10.3389/fmed.2025.1654429
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T22:05:43.176Z
- SHA-256 of the archived text
b3a3967130f4c3d3b90fbdb8177e8bb879ea1282d7c67481039b1888be0c78b8- Stable URL of this page
https://metraipolis.com/documento/dc_11237fc5a49b
How to cite
Beyond the hype: re-evaluating efficacy metrics and modeling rigor for MSC-EVs-based therapy in acute brain injury — Europe PMC PMID:41426594 — Europe PMC (en), https://europepmc.org/article/MED/41426594 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_11237fc5a49b (Metraipolis archive dc_11237fc5a49b, sha256 b3a3967130f4c3d3b90fbdb8177e8bb879ea1282d7c67481039b1888be0c78b8)
BibTeX
@misc{dc11237fc5a49b,
title = {Beyond the hype: re-evaluating efficacy metrics and modeling rigor for MSC-EVs-based therapy in acute brain injury — Europe PMC PMID:41426594},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41426594},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_11237fc5a49b; sha256 b3a3967130f4c3d3b90fbdb8177e8bb879ea1282d7c67481039b1888be0c78b8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41426594. Agents can read the archived copy with the MCP tool read_document.